"Being named a finalist for the Prix Galien USA awards is a great honor.
We congratulate the dedicated employees, researchers and physicians who make
it possible for this important medicine to help patients every day," said
The Prix Galien USA Awards committee of 11, including seven Nobel Laureates, recognizes the technical, scientific and clinical research skills necessary to develop innovative medicines that improve the human condition, and is considered the industry's highest accolade for pharmaceutical research and development.
About Ranexa(R)
In the United Sates, Ranexa(R) (ranolazine extended-release tablets) is
indicated for the treatment of chronic angina in patients who have not
achieved an adequate response with other antianginal drugs. In
About CV Therapeutics
CV Therapeutics, Inc., headquartered in
CV Therapeutics' approved products in
Except for the historical information contained herein, the matters set
forth in this press release, including statements as to research and
development and commercialization of products, are forward-looking statements
within the meaning of the "safe harbor" provisions of the Private Securities
Litigation Reform Act of 1995. These forward-looking statements are subject to
risks and uncertainties that may cause actual results to differ materially,
including operating losses and fluctuations in operating results; capital
requirements; regulatory review and approval of our products; special protocol
assessment agreement; the conduct and timing of clinical trials;
commercialization of products; market acceptance of products; product
labeling; concentrated customer base; reliance on strategic partnerships and
collaborations; uncertainties in drug development; uncertainties regarding
intellectual property and other risks detailed from time to time in
CV Therapeutics' SEC reports, including its Quarterly Report on Form 10-Q for
the quarter ended
SOURCE CV Therapeutics, Inc.